These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 12419832)

  • 41. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.
    Nöthlings U; Yamamoto JF; Wilkens LR; Murphy SP; Park SY; Henderson BE; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2098-106. PubMed ID: 19549810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer.
    Welfare M; Monesola Adeokun A; Bassendine MF; Daly AK
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):289-92. PubMed ID: 10207630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast cancer: role of polymorphisms in biotransformation enzymes.
    Sarmanová J; Sůsová S; Gut I; Mrhalová M; Kodet R; Adámek J; Roth Z; Soucek P
    Eur J Hum Genet; 2004 Oct; 12(10):848-54. PubMed ID: 15280903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan.
    Kobayashi M; Otani T; Iwasaki M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Sakamoto H; Yoshida T; Tsugane S
    Scand J Gastroenterol; 2009; 44(8):952-9. PubMed ID: 19452301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.
    Krajinovic M; Ghadirian P; Richer C; Sinnett H; Gandini S; Perret C; Lacroix A; Labuda D; Sinnett D
    Int J Cancer; 2001 Apr; 92(2):220-5. PubMed ID: 11291049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
    Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
    Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
    Landi S; Gemignani F; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; de Oca J; Capellà G; Canzian F;
    Pharmacogenet Genomics; 2005 Aug; 15(8):535-46. PubMed ID: 16006997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort.
    Agudo A; Peluso M; Sala N; Capellá G; Munnia A; Piro S; Marín F; Ibáñez R; Amiano P; Tormo MJ; Ardanaz E; Barricarte A; Chirlaque MD; Dorronsoro M; Larrañaga N; Martínez C; Navarro C; Quirós JR; Sánchez MJ; González CA
    Carcinogenesis; 2009 Jun; 30(6):968-76. PubMed ID: 19307236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
    Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
    Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
    Habalová V; Salagovic J; Kalina I; Stubna J
    Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.
    Zhao ZQ; Guan QK; Yang FY; Zhao P; Zhou B; Chen ZJ
    Tumour Biol; 2012 Apr; 33(2):523-35. PubMed ID: 22161138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.
    Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N
    Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
    Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
    Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
    Balta G; Yuksek N; Ozyurek E; Ertem U; Hicsonmez G; Altay C; Gurgey A
    Am J Hematol; 2003 Jul; 73(3):154-60. PubMed ID: 12827651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.